These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28935557)

  • 1. Combination of PTH (1-34) with anti-IL17 prevents bone loss by inhibiting IL-17/N-cadherin mediated disruption of PTHR1/LRP-6 interaction.
    Mansoori MN; Shukla P; Singh D
    Bone; 2017 Dec; 105():226-236. PubMed ID: 28935557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction.
    Yang H; Dong J; Xiong W; Fang Z; Guan H; Li F
    Ann N Y Acad Sci; 2016 Dec; 1385(1):41-52. PubMed ID: 27723935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.
    Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R
    J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions.
    Shukla P; Mansoori MN; Singh D
    Bone; 2018 May; 110():84-95. PubMed ID: 29414600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of PTH therapy amplifies bone loss by increasing oxidative stress: An event ameliorated by sequential IL-17 neutralizing antibody therapy.
    Singh KB; Rai R; Khanka S; Singh D
    Biomed Pharmacother; 2022 Jan; 145():112390. PubMed ID: 34839260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLPI is a critical mediator that controls PTH-induced bone formation.
    Morimoto A; Kikuta J; Nishikawa K; Sudo T; Uenaka M; Furuya M; Hasegawa T; Hashimoto K; Tsukazaki H; Seno S; Nakamura A; Okuzaki D; Sugihara F; Ninomiya A; Yoshimura T; Takao-Kawabata R; Matsuda H; Ishii M
    Nat Commun; 2021 Apr; 12(1):2136. PubMed ID: 33837198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone-protective effect of genistein in the animal model of bilateral ovariectomy: roles of phytoestrogens and PTH/PTHR1 against post-menopausal osteoporosis.
    Miao Q; Li JG; Miao S; Hu N; Zhang J; Zhang S; Xie YH; Wang JB; Wang SW
    Int J Mol Sci; 2012; 13(1):56-70. PubMed ID: 22312238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast and long acting neoflavonoids dalbergin isolated from Dalbergia sissoo heartwood is osteoprotective in ovariectomized model of osteoporosis: Osteoprotective effect of Dalbergin.
    Choudhary D; Kushwaha P; Gautam J; Kumar P; Verma A; Kumar A; Maurya SW; Siddiqui IR; Mishra PR; Maurya R; Trivedi R
    Biomed Pharmacother; 2016 Oct; 83():942-957. PubMed ID: 27522257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
    Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
    J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
    Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
    Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model.
    Perosky JE; Khoury BM; Jenks TN; Ward FS; Cortright K; Meyer B; Barton DK; Sinder BP; Marini JC; Caird MS; Kozloff KM
    Bone; 2016 Dec; 93():79-85. PubMed ID: 27641475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss.
    Weske S; Vaidya M; Reese A; von Wnuck Lipinski K; Keul P; Bayer JK; Fischer JW; Flögel U; Nelsen J; Epple M; Scatena M; Schwedhelm E; Dörr M; Völzke H; Moritz E; Hannemann A; Rauch BH; Gräler MH; Heusch G; Levkau B
    Nat Med; 2018 May; 24(5):667-678. PubMed ID: 29662200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone.
    Hunziker J; Wronski TJ; Miller SC
    J Dent Res; 2000 Jun; 79(6):1431-8. PubMed ID: 10890724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic effects of intermittent PTH on osteoblasts.
    Greenfield EM
    Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.
    Zhang D; Hu M; Chu T; Lin L; Wang J; Li X; Ke HZ; Qin YX
    Bone; 2016 Jun; 87():161-8. PubMed ID: 26868528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone induces bone formation in phosphorylation-deficient PTHR1 knockin mice.
    Datta NS; Samra TA; Abou-Samra AB
    Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1183-8. PubMed ID: 22338074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
    Jin X; Zhu L; Li X; Jia J; Zhang Y; Sun X; Ma J; Liu Z; Ma X
    Mol Med Rep; 2017 Feb; 15(2):890-898. PubMed ID: 28000877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH.
    Bedi B; Li JY; Tawfeek H; Baek KH; Adams J; Vangara SS; Chang MK; Kneissel M; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):E725-33. PubMed ID: 22393015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.